| SNNA Shares Outstanding History Table | ||||||||||||||||||||||||||
Below is a table of the SNNA shares outstanding history going back to 7/27/2017:
Also see: SNNA Market Cap History SNNA YTD Return |
SNNA Shares Outstanding History — Sienna Biopharmaceuticals Share Count Over Time
As of 11/7/2019 Sienna Biopharmaceuticals has 30.91 million SNNA shares outstanding. Investors often track the SNNA shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows SNNA share count trends over time, with 12 historical shares outstanding datapoints presented, dating back to 7/27/2017.
| SNNA Shares Outstanding History Chart | |||||||||||||||||||||||||||
SNNA Historical Shares Outstanding: +21.31% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||
| SNNA Stock Price Chart |
| About Sienna Biopharmaceuticals Inc |
| Sienna Biopharmaceuticals is a clinical-stage biopharmaceutical company. Co.'s primary product candidates from its technological platform are SNA-120 (pegcantratinib), a first-in-class TrkA inhibitor for the topical treatment of psoriasis, as well as the associated pruritus; and SNA-125, a topical JAK3/TrkA inhibitor with the potential to treat various inflammatory conditions, including atopic dermatitis, psoriasis and the associated pruritus. Co.'s second technology platform, Topical Photoparticle Therapy™, utilizes silver particles applied to the skin to direct the light from commercially available lasers to the hair follicle or sebaceous gland to cause selective photothermolysis. We show 12 historical shares outstanding datapoints in our coverage of SNNA's shares outstanding history. Understanding the changing numbers of SNNA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SNNA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SNNA by allowing them to research SNNA shares outstanding history as well as any other stock in our coverage universe. |
| SNNA Current Stock Quote |
Quotes delayed 20 minutes  Free SNNA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| SNNA Share Performance |
| Shares Outstanding Peers |
| Sienna Biopharmaceuticals (SNNA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
SNOA Shares Outstanding History SNPX Shares Outstanding History SNSE Shares Outstanding History SNSS Shares Outstanding History SOLV Shares Outstanding History SOLY Shares Outstanding History SONN Shares Outstanding History SONX Shares Outstanding History SPEX Shares Outstanding History SPNE Shares Outstanding History More Healthcare companies » |
SNNA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
